| | |
| Clinical data | |
|---|---|
| Other names | Egyt 402; O-Methylisoprenaline; Methylprenaline; 3-Methoxyisoprenaline; MOXA; 3-Methoxyisoproterenol; 3-O-Methylisoprenaline; 3-O-Methylisoproterenol |
| Drug class | Bronchodilator |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H19NO3 |
| Molar mass | 225.288 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Metiprenaline (INN Tooltip International Nonproprietary Name; developmental code name Egyt 402), also known as 3-O-methylisoprenaline, is a bronchodilator which was never marketed. [1] [2] It is the 3-O-methyl derivative of isoprenaline (isoproterenol). [1] [2]
| Phenethylamines |
|
|---|---|
| Amphetamines |
|
| Phentermines |
|
| Cathinones |
|
| Phenylisobutylamines | |
| Phenylalkylpyrrolidines | |
| Catecholamines (and close relatives) |
|
| Miscellaneous |
|
| | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |